Back to search
πŸ‡ΊπŸ‡Έ

United States Β· US Β· US:0074-1044_998985bb-7cd1-4e80-bd08-8fc7c503f982

EMRELIS

UNIISPL

Last synced from FDA National Drug Code directory (United States) on

Identification

ManufacturerAbbVie Inc.
CountryUS (United States)
ATC codeβ€”
Dispensingβ€”
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026

Packs Β· 1

  • ndc11
    0074104401
    1 VIAL, SINGLE-DOSE in 1 CARTON (0074-1044-01) / 1 mL in 1 VIAL, SINGLE-DOSE

Annotations

UNII (FDA Substance ID)
976X9VXC3Z
TELISOTUZUMAB VEDOTIN
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
  "unii": {
    "unii": "976X9VXC3Z",
    "rxcui": null,
    "inchikey": null,
    "display_name": "TELISOTUZUMAB VEDOTIN",
    "substance_type": "protein",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "INTRAVENOUS",
  "spl_meta": {
    "bc04f980-3957-4e35-ab81-8ec2ffe87215": {
      "match": "brand_token",
      "title": "EMRELIS (TELISOTUZUMAB VEDOTIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ABBVIE INC.]",
      "spl_version": "3",
      "published_date": "2025-07-10"
    }
  },
  "productid": "0074-1044_998985bb-7cd1-4e80-bd08-8fc7c503f982",
  "productndc": "0074-1044",
  "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "TELISOTUZUMAB VEDOTIN",
  "proprietary_name": "EMRELIS",
  "active_ingred_unit": "mg/mL",
  "application_number": "BLA761384",
  "marketing_category": "BLA",
  "nonproprietary_name": "Telisotuzumab Vedotin",
  "start_marketing_date": "20250514",
  "active_numerator_strength": "20"
}

Access this data programmatically

Query EMRELIS and 610,000+ other drug records through a single REST API β€” with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.

EMRELIS (US) β€” Drug Database